✦ LIBER ✦

The new British Society for Rheumatology disease modifying anti-rheumatic drugs guidelines

✍ Scribed by Chris Deighton; Kate Gadsby

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 111 KB
Volume: 4
Category: Article
ISSN: 1478-2189
DOI: 10.1002/msc.88

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of the British society for rheu

The role of the British society for rheumatology biologics register (BSRBR) and the NICE guidelines for anti - TNF therapy

✍ Kath Watson; Kimme Hyrich 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Rheumatoid arthritis (RA) is a chronic disease characterized by inflammation and destruction of the synovial joints (Wollheim, 1998) resulting in marked disability and morbidity. With an estimated adult prevalence in the UK of around 1% for females and half that for males (Symmons et al., 2002) the

Comparison of the response to infliximab

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register

✍ Kimme L. Hyrich; Deborah P. M. Symmons; Kath D. Watson; Alan J. Silman; British 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## Abstract ## Objective To compare outcome at 6 months in unselected “real‐world” patients with rheumatoid arthritis treated with etanercept or infliximab as either monotherapy, cotherapy with methotrexate (MTX), or cotherapy with another disease‐modifying antirheumatic drug (DMARD). ## Methods